Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Cannabics Pharmaceuticals Inc (CNBX)

Cannabics Pharmaceuticals Inc (CNBX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
/C O R R E C T I O N -- Cannabics Pharmaceuticals Inc./

In the news release, Cannabics Pharmaceuticals Appoints Two Independent Directors, issued June 25, 2019 by Cannabics Pharmaceuticals Inc. over PR Newswire, we are advised by the company that the 5th paragraph,...

CNBX : 0.2700 (-0.37%)
Cannabics Pharmaceuticals Appoints Two Independent Directors

TEL AVIV , Israel and BETHESDA, Maryland, June 25, 2019 /PRNewswire/ -- Cannabics Pharmaceuticals Inc.   (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused...

CNBX : 0.2700 (-0.37%)
Cannabics Pharmaceuticals Appoints Two Independent Directors

Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, today announced that it has appointed two new independent directors to...

CNBX : 0.2700 (-0.37%)
Cannabics Pharmaceuticals to Participate at the 9th Annual LD Micro Invitational in Bel Air, California

Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, today announced that it will be presenting at the 9th annual LD Micro...

CNBX : 0.2700 (-0.37%)
Cannabics Pharmaceuticals to Participate at the 9th Annual LD Micro Invitational in Bel Air, California

TEL AVIV, Israel and BETHESDA, Maryland , May 30, 2019 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side...

CNBX : 0.2700 (-0.37%)
Cannabics Pharmaceuticals Announces Initiation of a Nationwide Clinical Study to Evaluate Antitumor Properties of Cannabinoid Compounds on Primary Cancer Biopsies

TEL AVIV , Israel and BETHESDA, Maryland , April 17, 2019 /PRNewswire/ -- Cannabics Pharmaceuticals Inc.   (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused...

CNBX : 0.2700 (-0.37%)
Cannabics Pharmaceuticals Announces Initiation of a Nationwide Clinical Study to Evaluate Antitumor Properties of Cannabinoid Compounds on Primary Cancer Biopsies

Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, today announced that it has obtained approval for a nationwide Israeli...

CNBX : 0.2700 (-0.37%)
OTC Markets Group Announces Gold Sponsorship of 31st Annual ROTH Conference

OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today unveiled the list of OTCQX® Best Market and OTCQB® Venture Market company presentations...

EVLLF : 0.7600 (+0.33%)
TRLFF : 0.2845 (-4.59%)
AITB : 5.16 (-0.77%)
BICXD : 4.5400 (-9.02%)
MMNFF : 2.4400 (+2.09%)
ATEA : 5.9600 (+3.11%)
CWBHF : 13.6700 (+3.95%)
CVSI : 3.9300 (-0.72%)
DUOT : 0.8000 (+1.27%)
CRLBF : 10.6480 (-0.10%)
ARREF : 0.5245 (+0.87%)
CLOK : 0.9479 (-0.21%)
MLCPF : 3.5200 (+11.47%)
CNBX : 0.2700 (-0.37%)
HEOFF : 0.8548 (-8.49%)
MJARF : 1.1580 (+8.45%)
ALEAF : 0.9250 (+25.51%)
OTCM : 31.8600 (-8.58%)
NUPMF : 1.8400 (-0.54%)
GLDLF : 0.6973 (-4.48%)
NMUS : 0.6500 (-9.52%)
NLST : 0.3290 (-0.30%)
GBPT : 0.3000 (+5.93%)
IMLFF : 0.2671 (-3.75%)
KSHB : 4.6250 (+4.99%)
CORVF : 1.7000 (+1.19%)
ELLXF : 2.5300 (+1.61%)
RSSS : 2.4000 (+0.42%)
ISYRF : 0.9150 (+4.21%)
FLUX : 1.0300 (+3.00%)
NWGI : 0.3200 (+6.35%)
QBIO : 1.5300 (unch)
WIZD : 0.1800 (+12.50%)
MRMD : 2.1200 (-0.93%)
GRWG : 3.2600 (+7.24%)
BRTI : 0.1100 (-24.19%)
GTBP : 0.2500 (-3.81%)
MRIC : 3.1000 (unch)
DYAI : 6.00 (+2.92%)
GTBIF : 11.1400 (+6.85%)
MTAFF : 0.7900 (-2.84%)
EMHTF : 1.7700 (-1.67%)
ITHUF : 3.1620 (-0.31%)
ALYE : 4.0000 (+14.29%)
VTLR : 0.1411 (+14.62%)
ARHH : 1.2000 (-4.76%)
OWCP : 0.0159 (-6.47%)
STLHF : 0.6690 (+1.03%)
PPCB : 0.0068 (-9.33%)
ARTH : 0.3200 (+10.34%)
ACRGF : 16.9715 (-0.28%)
Cannabics Pharmaceuticals Closes Agreement With Wize Pharma

Cannabics Pharmaceuticals Inc. (OTCQB: CNBX) a world leader in personalized cannabinoid medicine focused on cancer and its side effects, today announced that it has closed an agreement with Wize Pharma,...

WIZP : 0.5000 (-3.85%)
CNBX : 0.2700 (-0.37%)
Cannabics Pharmaceuticals Closes Agreement With Wize Pharma

BETHESDA, Maryland and TEL AVIV, Israel, March 6, 2019 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX) a world leader in personalized cannabinoid medicine focused on cancer and its...

WIZP : 0.5000 (-3.85%)
CNBX : 0.2700 (-0.37%)
Wize Pharma, Inc. Closes Deal to Launch Joint Venture With Cannabics

Wize Pharma, Inc. ("Wize Pharma" or the "Company") (OTCQB: WIZP) a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, today announced that the Company closed a deal...

WIZP : 0.5000 (-3.85%)
CNBX : 0.2700 (-0.37%)
Wize Pharma, Inc. Closes Deal to Launch Joint Venture With Cannabics

WIZP : 0.5000 (-3.85%)
CNBX : 0.2700 (-0.37%)
Cannabics Pharmaceuticals Submits Protocol for an Ex-Vivo Clinical Study on Biopsies and Cannabinoids

Cannabics Pharmaceuticals Inc. (OTCQB:CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, today announced that it has submitted a protocol for the Helsinki Committee...

CNBX : 0.2700 (-0.37%)
Cannabics Pharmaceuticals Submits Protocol for an Ex-Vivo Clinical Study on Biopsies and Cannabinoids

CNBX : 0.2700 (-0.37%)
Consumers Turn to CBD Products Due to their Non-Psychoactive Nature

Cannabidiol, or CBD-based, products are appearing everywhere throughout the U.S., whether it's for healthcare and wellness, beauty, pets, medicinal, or even just purely recreational use. CBD is known to...

GRBX : 0.1300 (-2.48%)
HIPHD : 0.1100 (+22.22%)
CBWTF : 0.5658 (+6.35%)
HIPH : 0.0265 (-3.64%)
ALEAF : 0.9250 (+25.51%)
WRLD.CN : 0.385 (-8.33%)
CNBX : 0.2700 (-0.37%)
Consumers Turn to CBD Products Due to their Non-Psychoactive Nature

FinancialBuzz.com News Commentary

GRBX : 0.1300 (-2.48%)
HIPHD : 0.1100 (+22.22%)
CBWTF : 0.5658 (+6.35%)
HIPH : 0.0265 (-3.64%)
ALEAF : 0.9250 (+25.51%)
WRLD.CN : 0.385 (-8.33%)
CNBX : 0.2700 (-0.37%)
Cannabics Pharmaceuticals and Wize Pharma to Form Joint Venture to Develop Cannabinoid Based Ophthalmic Therapeutics

Cannabics Pharmaceuticals Inc. (OTCQB: CNBX) a world leader in personalized cannabinoid medicine focused on cancer and its side effects, today announced that it has entered into agreement with Wize Pharma,...

WIZP : 0.5000 (-3.85%)
CNBX : 0.2700 (-0.37%)
Cannabics Pharmaceuticals and NewCanna Hub Intend to Collaborate to Manufacture and Market Cannabics' SR Capsules in Colombia

TEL AVIV, Israel and BETHESDA, Maryland , Jan. 24, 2019 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and...

CNBX : 0.2700 (-0.37%)
Cannabics Pharmaceuticals to Co-Sponsor the Canada Cannabis House at the World Economic Forum in Davos

CNBX : 0.2700 (-0.37%)
Cannabics Pharmaceuticals to Co-Sponsor the Canada Cannabis House at the World Economic Forum in Davos

Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced that Mr. Eyal Barad, Co-Founder and CEO, and Dr. Eyal Ballan,...

CNBX : 0.2700 (-0.37%)

Van Meerten Stock Picks

Ball Corp
My Stock Pick of the Day belongs to the packaging products company Ball Corp(BLL).
BLL -0.31
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar